Search

In Stock

Camosunate Junior (7-13 years)

Camosunate Junior (7-13 years) is used for treating chloroquine resistant malaria, severe quinine resistant malaria and other forms of malaria infection. It contains Artesunate and Amodiaquine as active ingredients. It works by inhibiting heme polymerase activity in the body; killing the malarial parasite

850.00

Compare

Camosunate Junior (7-13 years) is an anti-malaria drug that contains artesunate and amodiaquine as its active pharmaceutical ingredient. It is indicated for the treatment of acute uncomplicated malaria attacks, including multi drug resistant strains of Plasmodium falciparum.

It comes in a blister of 6 tablets containing 3 white Artesunate tablets and 3 yellow Amodiaquine tablets. Each white tablet contains artesunate 100 mg. Each yellow tablet contains Amodiaquine 300 mg.

Back to Top
Product has been added to your cart